NETest: serial liquid biopsies in gastroenteropancreatic NET surveillance

NETest: serial liquid biopsies in gastroenteropancreatic NET surveillance

Objective: Up to now, serial NETest measurements in individuals assessing the disease course of gastroenteropancreatic neuroendocrine tumors (GEPNETs) at long-term follow-up and treatment response were not studied. Design: The study was a longitudinal validation study of serial NETest measurements...

Full description

Bibliographic Details
Main Authors:	Mark J C van Treijen, Catharina M Korse, Wieke H Verbeek, Margot E T Tesselaar, Gerlof D Valk
Format:	Article
Language:	English
Published:	Bioscientifica 2022-09-01
Series:	Endocrine Connections
Subjects:	gastroenteropancreatic neuroendocrine tumors liquid biopsy treatment response surveillance gene expression signature
Online Access:	https://ec.bioscientifica.com/view/journals/ec/11/10/EC-22-0146.xml

Similar Items

Initial validation of the clinical significance of the NETest in Japanese gastroenteropancreatic neuroendocrine tumor patients
by: Hao Zhang, et al.
Published: (2024-09-01)

Gastroenteropancreatic neuroendocrine tumours – an overview
by: Karol Maciejewski, et al.
Published: (2022-12-01)

Liver metastases in gastroenteropancreatic neuroendocrine tumours – treatment methods
by: Paweł Gut
Published: (2020-01-01)

Circulating Angiogenic Markers in Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review
by: Irina Sandra, et al.
Published: (2022-09-01)

Gastroenteropancreatic neuroendocrine neoplasms: epidemiology, genetics, and treatment
by: Baizhou Tan, et al.
Published: (2024-09-01)

Clinicopathologic Features of Gastroenteropancreatic Neuroendocrine Tumors: A Single-center Experience
by: Tuğba Akın Telli, et al.
Published: (2020-09-01)

Gastroenteropancreatic neuroendocrine tumors in children and adolescents
by: Ülkü Miray Yıldırım, et al.
Published: (2024-07-01)

Evolving landscape of clinical trials in gastroenteropancreatic neuroendocrine neoplasms in the past two decades
by: Kaili Yang, et al.
Published: (2023-03-01)

Site‐specific trends in gastroenteropancreatic neuroendocrine neoplasms in Bavaria, Germany
by: Nina Grundmann, et al.
Published: (2023-10-01)

Inflammation Related to Obesity in the Etiopathogenesis of Gastroenteropancreatic Neuroendocrine Neoplasms
by: Marlena Budek, et al.
Published: (2022-10-01)

Characteristics and treatment results of patients with gastroenteropancreatic neuroendocrine tumors in a tertiary care centre
by: Shouki Bazarbashi, et al.
Published: (2023-04-01)

Role of endoscopic submucosal dissection in treatment of rectal gastroenteropancreatic neuroendocrine neoplasms
by: Michał Spychalski, et al.
Published: (2016-12-01)

Incidence trend and conditional survival estimates of gastroenteropancreatic neuroendocrine tumors: A large population‐based study
by: Qing Zhong, et al.
Published: (2018-07-01)

Platinum-doublet chemotherapy for advanced gastroenteropancreatic neuroendocrine carcinoma: a systematic review and meta-analysis
by: Akihiro Ohmoto, et al.
Published: (2022-05-01)

Gastroenteropancreatic neuroendocrine neoplasms: current development, challenges, and clinical perspectives
by: Xian-Bin Zhang, et al.
Published: (2024-06-01)

Artificial Intelligence and Machine Learning in the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms—A Scoping Review
by: Athanasios G. Pantelis, et al.
Published: (2022-03-01)

Diagnostic Management of Gastroenteropancreatic Neuroendocrine Neoplasms: Technique Optimization and Tips and Tricks for Radiologists
by: Fabio Pellegrino, et al.
Published: (2023-01-01)

Satisfaction and quality of life in patients with symptomatic gastroenteropancreatic neuroendocrine tumours treated with lanreotide Autogel in South Africa
by: Daleen Geldenhuys, et al.
Published: (2020-10-01)

Epidemiologic trends and survival of early-onset gastroenteropancreatic neuroendocrine neoplasms
by: Hailing Yao, et al.
Published: (2023-08-01)

Relationship between clinical characteristics and survival of gastroenteropancreatic neuroendocrine neoplasms: A single-institution analysis (1995–2012) in South China
by: Wang Yu-hong, et al.
Published: (2012-11-01)

Emerging developments in immune checkpoint inhibitor therapy for gastroenteropancreatic neuroendocrine neoplasm
by: HAN Xu, WANG Wenquan, LOU Wenhui, LIU Liang
Published: (2023-05-01)

Current treatment options for gastroenteropancreatic neuroendocrine tumors with a focus on the role of lanreotide
by: Beata Kos-Kudła, et al.
Published: (2017-06-01)

Risk factors, prognostic factors, and nomograms for distant metastases in patients with gastroenteropancreatic neuroendocrine tumors: a population-based study
by: Xinwei Li, et al.
Published: (2024-02-01)

Real-World Study of Lanreotide Autogel in Routine Practice in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Hong Kong and Taiwan
by: Jen-Shi Chen, et al.
Published: (2024-08-01)

Establishment and validation of a clinicopathological prognosis model of gastroenteropancreatic neuroendocrine carcinomas
by: Jing Chen, et al.
Published: (2022-09-01)

Meeting Notes of the Taiwan Neuroendocrine Tumor Society & Taiwan Society of Nuclear Medicine Joint Conference - Peptide Receptor Radionuclide Therapy Targeting for Gastroenteropancreatic Neuroendocrine Tumors: Basic Principles and State-of-the-art Clinical Practice
by: Mei-Fang Cheng, et al.
Published: (2024-06-01)

Evaluation of PD-L1 expression in a large set of gastroenteropancreatic neuroendocrine tumours and correlation with clinicopathological data
by: Erik Rösner, et al.
Published: (2022-11-01)

First-line treatment of camrelizumab combined with chemotherapy in advanced gastroenteropancreatic neuroendocrine carcinoma: Study protocol for a prospective, multicenter, phase II study
by: Xiaofen Li, et al.
Published: (2022-09-01)

Exploring the expression of DLL3 in gastroenteropancreatic neuroendocrine neoplasms and its potential diagnostic value
by: L. Yin, et al.
Published: (2025-01-01)

Somatostatin Receptor Targeted PET-CT and Its Role in the Management and Theranostics of Gastroenteropancreatic Neuroendocrine Neoplasms
by: Aadil Adnan, et al.
Published: (2023-06-01)

Gastroenteropancreatic Neuroendocrine Tumors—Current Status and Advances in Diagnostic Imaging
by: Daniel Vogele, et al.
Published: (2023-08-01)

Advances in preclinical research models for gastroenteropancreatic neuroendocrine neoplasm
by: CUI Lingjun, TIAN Chao, CHENG Zixuan, ZHENG Jiabin, SU Fei, TAN Huangying
Published: (2022-09-01)

Investigating the causal relationship between gut microbiota and gastroenteropancreatic neuroendocrine neoplasms: a bidirectional Mendelian randomization study
by: Chun-yu Zhang, et al.
Published: (2024-08-01)

Narrative Review of Immunotherapy in Gastroentero-Pancreatic Neuroendocrine Neoplasms
by: Jasmeet Kaur, et al.
Published: (2023-09-01)

The Interplay of Four Main Pathways Recomposes Immune Landscape in Primary and Metastatic Gastroenteropancreatic Neuroendocrine Tumors
by: Xin Lou, et al.
Published: (2022-05-01)

Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors
by: Yibo Cai, et al.
Published: (2022-07-01)

Prospective Evaluation of <i>MGMT</i>-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors
by: Nicole Brighi, et al.
Published: (2023-01-01)

Clinicopathological correlations in 38 cases of gastroenteropancreatic high-grade neuroendocrine neoplasms
by: Na Li, et al.
Published: (2024-10-01)

The Role of Genetics in Sporadic GEP-NETs: A Comprehensive Review of the Literature
by: Fotopoulos George, et al.
Published: (2017-06-01)

Observational Study on Antibody Response to COVID-19 Vaccines in PAtients with Gastro-Entero-PanCreatic Cancers and NeuroendocrIne NeoplAsms on Systemic TreatmEnts (VACCINATE)
by: Alice Laffi, et al.
Published: (2023-01-01)